Blood clots and heart ultrasound in people with device-detected afib
Part of Heart & circulation clinical trials.
This study looks at blood clotting markers and heart ultrasound in people who have a pacemaker or defibrillator that has detected short episodes of atrial fibrillation (afib). The goal is to better understand stroke risk and help guide future treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 50 years old
- You have a pacemaker or defibrillator with a wire inside the heart (atrial lead)
- Your device has detected at least one episode of atrial fibrillation lasting 1 minute or more in the last year
- You have not had atrial fibrillation seen on a standard heart tracing (ECG) before
- You have not taken blood thinners or two antiplatelet medicines together in the last 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients who have a heart rhythm device (pacemaker, defibrillator, or resynchronization device) and have experienced brief episodes of fast irregular heartbeats detected by the device. The study compares treatment approaches to understand which helps patients stay healthier and feel better.
This study looks at stroke risk and blood clotting in people who have just been diagnosed with atrial fibrillation (AFib) that is not caused by a heart valve problem, and who have not yet taken blood thinners. It aims to better understand how blood clots form in this condition.
This study looks at blood-related “clotting” signs and heart scan results in people with atrial fibrillation (AF) who are getting a catheter ablation. It may help doctors better understand AF and choose treatments more precisely.
This study looks at early changes in the heart related to atrial fibrillation (AF) using health data and biomarkers. It aims to find better ways to predict or understand AF, especially around procedures like ablation or cardioversion.
This study tests a new blood thinner to prevent strokes and blood clots in people with atrial fibrillation (a common heart rhythm problem). You may qualify if you have atrial fibrillation and at least one risk factor for stroke, or if you've never taken a blood thinner before.
This trial tests how well blood thinners (anticoagulants) work to dissolve clots in the heart of people with atrial fibrillation (an irregular heartbeat). It aims to find the best treatment for these clots before more serious complications occur.
Hear when a new Device-detected Atrial Fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.